相关实验视频
Updated: Sep 9, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
在黑色素瘤细胞表型切换中ARHGAP29的新兴作用
Beatrice Charlotte Tröster1, Melanie Kappelmann-Fenzl1,2, Anja Katrin Bosserhoff1,3,4
1Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Molecular oncology
|September 4, 2025
概括
通过调节RhoA/ ROCK通路和细胞可塑性,促进黑色素瘤细胞的侵入. 这项研究确定ARHGAP29是黑色素瘤进展的关键驱动因素和潜在的治疗点.
科学领域:
- 癌症学
- 细胞生物学
- 分子生物学
背景情况:
- 已知Rho GTPase激活蛋白29 (ARHGAP29) 能调节actin细胞骨并促进非黑色素瘤癌症的侵袭.
- 在黑色素瘤 (一种显著的皮肤癌) 中,ARHGAP29的功能仍未确定.
- 与正常黑色素细胞相比,转录组分析显示黑色素瘤细胞系的ARHGAP29表达显著增加.
研究的目的:
- 研究ARHGAP29在黑色素瘤中的功能作用.
- 确定ARHGAP29是否影响黑色素瘤细胞迁移和进展.
- 阐明黑色素瘤中由ARHGAP29调节的下游信号通路.
主要方法:
- 转录组分析以比较ARHGAP29的表达.
- 在黑色素瘤细胞系中进行ARHGAP29敲击实验.
- 细胞形态,迁移和RhoA/ROCK通路活动的评估.
- 研究ARHGAP29对SMAD活性和瘤细胞可塑性的影响.
主要成果:
- 在黑色素瘤细胞中,ARHGAP29的表达被上调.
- 对ARHGAP29的抑制改变了细胞形态,促进了较少传播的表型.
- ARHGAP29 调节RhoA/ ROCK 信号通路.
- ARHGAP29影响SMAD活动,并促进细胞间类似的侵入性表型,表明瘤细胞的可塑性得到增强.
结论:
- 在促进黑色素瘤细胞入侵和进展方面,ARHGAP29起着至关重要的作用.
- 在黑色素瘤中,RhoA/ ROCK通路和SMAD活性是ARHGAP29的关键下游作用因子.
- ARHGAP29是治疗黑色素瘤的一种新且有前途的治疗点.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cell Polarization by Rho Proteins
2.8K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K

